Cronos Group Inc (CRON)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $1.24B
Last updated: Nov 17, 2026 at 11:04 AM ET
Cronos Group Inc (CRON) Stock Forecast
Analysts expect Cronos Group (CRON) to earn $0.26 per share in the fiscal year ending Dec 31, 2026, on revenue of $322.06M. Of 5 analysts, 4 rate the stock Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 3 estimates for the fiscal year ending Dec 31, 2026 were revised up and 2 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 5 ratings average 2.20, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 80% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 4 | 80.0% |
| Hold | 1 | 20.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 5
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus falls 3.8% and revenue estimates rise 24.0%.
- Fiscal year ending Dec 31, 2026
- $0.26
- EPS consensus, revenue $322.06M
- Fiscal year ending Dec 31, 2027
- $0.25
- EPS consensus, revenue $399.43M
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.26 | $0.18 to $0.35 | 5 | $322.06M | $316.08M to $325.09M | 4 |
| Dec 31, 2027 | $0.25 | $0.18 to $0.37 | 5 | $399.43M | $360.95M to $418.13M | 5 |
Quarterly Estimates
The EPS consensus rises from $0.04 for the quarter ending Dec 31, 2026 to $0.07 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.04 | $0.03 to $0.05 | 5 | $68.00M | $62.92M to $71.50M | 6 |
| Mar 31, 2027 | $0.07 | $0.04 to $0.09 | 3 | $95.50M | $87.73M to $100.94M | 3 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 5 upward and 4 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 3 | 2 |
| Fiscal year ending Dec 31, 2027 | 2 | 2 |
| Quarter ending Mar 31, 2027 | 0 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 18.2% from $0.22.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $0.26 | $0.24 | $0.22 | $0.22 | $0.22 | +17.4% |
| Fiscal year ending Dec 31, 2027 | $0.25 | $0.26 | $0.16 | $0.16 | $0.16 | +60.2% |
| Quarter ending Mar 31, 2027 | $0.07 | $0.08 | N/A | N/A | N/A | N/A |
Frequently Asked Questions About CRON
What is the CRON stock forecast?
Consensus analyst estimates put Cronos Group's EPS at $0.26 for the fiscal year ending Dec 31, 2026, on revenue of $322.06M. The consensus rating from 5 analysts is Buy.
How do analysts rate CRON stock?
Of 5 analysts covering Cronos Group, 0 rate it Strong Buy, 4 Buy, 1 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from CRON next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $0.26, with estimates from $0.18 to $0.35 from 5 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $0.25, with estimates from $0.18 to $0.37 from 5 analysts.
What revenue do analysts expect from Cronos Group next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $322.06M, with estimates from $316.08M to $325.09M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $399.43M, with estimates from $360.95M to $418.13M.
How many analysts cover CRON?
5 analysts rate Cronos Group stock, and 5 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
CRON pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors